Pharmaceutical companies' turnover contribution kept at 1% for 2008
Article 14 of the 2008 social security financing law set, on an exceptional basis, the rate of the contribution on pharmaceutical companies' turnover (Article L. 245-6 of the Social Security Code) at 1% for turnover earned in 2008. The same article set the K rate of the safeguard clause at 1.4% for 2008.
Measure originators
A positive amount is revenue or savings for public finances; a negative amount is a cost or lost revenue.
Measure impact
Concerns companies marketing reimbursable medicines, for turnover earned in 2008. Revenue estimated at around €100 million for social security.
Official references
Sources
Procedure timeline
Follow the progress of this fiscal measure through the different stages of the parliamentary procedure.
Administrative implementation
Entrée en vigueur de la mesure et mise en œuvre par l'administration
President of the Republic signature
Publication au Journal officiel
Possible referral to Constitutional Council
Décision de conformité / censure partielle
National Assembly has the final say
Si échec CMP
Joint committee
Désaccord éventuel
Debate and vote
Debate and vote
Débat et vote en séance publique à l'Assemblée nationale, ou engagement de la responsabilité du Gouvernement (article 49.3)